Anti-CD19 iCAR NK Cells

CD19-targeted iCAR NK cell therapy · Allife Medical Science and Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD19 iCAR NK Cells, covering 2019-01-31 to 2019-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma [EARLY_Phase 1]